activity
20202022
most citedSurvival analysis for AdVerse events with VarYing follow-up times (SAVVY) -- comparison of adverse event risks in randomized controlled trials

4 citations · 8 across the 4 of their papers we have counts for

collaborators
Showing 2021Show all

1 paper · 1 filter

stat.AP2021★ 1 cited

Decision rules for identifying combination therapies in open-entry, randomized controlled platform trials

Elias Laurin Meyer, Peter Mesenbrink, Cornelia Dunger-Baldauf +3

Platform trials have become increasingly popular for drug development programs, attracting interest from statisticians, clinicians and regulatory agencies. Many statistical questio…